Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Allogeneic T Cell Therapies Global Market Report 2025
Request Sample Buy Now
Global Allogeneic T Cell Therapies Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Allogeneic T Cell Therapies Global Market Report 2025

By Product Type (Chimeric Antigen Receptor (CAR) T Cell Therapies, T Cell Receptor (TCR) Therapies, Other Product Types), By Antigen Type (CD 19, CD 20, Egfrvlll, GD2, CD22, CD30, CD33, Meso, HER1, Other Antigen Types), By Therapeutics Indications (Cancer, Autoimmune Diseases, Infectious Diseases, Others Therapeutics Indications), By End-User (Hospitals, Specialty Clinics, Research Institutes, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Allogeneic T Cell Therapies Market Overview

• Allogeneic T Cell Therapies market size has reached to $1.16 billion in 2024

• Expected to grow to $1.81 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%

• Growth Driver: Increasing Cancer Cases Drive Demand For Innovative Therapies

• Market Trend: Innovative Solutions Enhanced Allogeneic T Cell Therapies Market Growth

• North America was the largest region in 2024.

What Is Covered Under Allogeneic T Cell Therapies Market?

Allogeneic T cell therapies are a type of medical treatment where T cells, a crucial component of the immune system, are obtained from a donor (rather than the patient) and used to target and destroy Cancer cells in the recipient. Allogeneic T-cell therapies are primarily used in the treatment of various cancers, particularly those that are difficult to treat with conventional methods.

The main types of allogeneic T cell therapies are chimeric antigen receptor (CAR) T cell therapies and T cell receptor (TCR) therapies. Chimeric antigen receptor (CAR) T-cell therapies are a type of immunotherapy where a patient's T-cells are genetically modified to target and destroy cancer cells. This treatment involves reprogramming T-cells to recognize specific proteins in cancer cells. The antigen types for these therapies include CD19, CD20, EgfrvIII, GD2, CD22, CD30, CD33, Meso, HER1, and others. These therapies are used for therapeutic indications such as cancer, autoimmune diseases, infectious diseases, and more, and are utilized by end users including hospitals, specialty clinics, research institutes, and others.

Allogeneic T Cell Therapies Market Size and growth rate 2025 to 2029: Graph

What Is The Allogeneic T Cell Therapies Market Size 2025 And Growth Rate?

The allogeneic t cell therapies market size has grown rapidly in recent years. It will grow from $1.16 billion in 2024 to $1.26 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to regulatory approvals, increasing cancer prevalence, rising clinical trials, government funding, and a growing geriatric population.

What Is The Allogeneic T Cell Therapies Market Growth Forecast?

The allogeneic t cell therapies market size is expected to see strong growth in the next few years. It will grow to $1.81 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to expanding indications, rising demand for cell-based immunotherapies, growing awareness about advanced therapies, increasing healthcare expenditure, and supportive reimbursement policies. Major trends in the forecast period include advancement in research and development activities, personalized medicine, off-the-shelf therapies, global market expansion, strategic partnerships, and regulatory landscape evolution.

The forecast of 9.4% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. cancer centers by driving up costs of donor-derived T cell therapies imported from the UK and Switzerland, exacerbating immunotherapy program expenses and increasing hematologic malignancy treatment burdens. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Allogeneic T Cell Therapies Market Segmented?

1) By Product Type: Chimeric Antigen Receptor (CAR) T Cell Therapies, T Cell Receptor (TCR) Therapies, Other Product Types

2) By Antigen Type: CD 19, CD 20, Egfrvlll, GD2, CD22, CD30, CD33, Meso, HER1, Other Antigen Types

3) By Therapeutics Indications: Cancer, Autoimmune Diseases, Infectious Diseases, Others Therapeutics Indications

4) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users

Subsegments:

1) By Chimeric Antigen Receptor (CAR) T Cell Therapies: CD19-targeted CAR T Therapies, BCMA-targeted CAR T Therapies, CD22-targeted CAR T Therapies

2) By T Cell Receptor (TCR) Therapies: Neoantigen-targeted TCR Therapies, Viral Antigen-targeted TCR Therapies

3) By Other Product Types: Engineered T Cell Therapies, NK Cell Therapies

What Is Driving The Allogeneic T Cell Therapies Market? Increasing Cancer Cases Drive Demand For Innovative Therapies

The increasing cases of cancer are expected to propel the growth of the allogeneic T cell therapies market going forward. Cancer refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. Cancer cases are rising due to factors such as longer lifespans, lifestyle changes, environmental exposures, infections, genetic factors, and changes in reproductive patterns, which collectively contribute to a higher incidence and detection of the disease. Allogeneic T cell therapies are used in cancer patients to target and kill cancer cells by infusing genetically engineered donor T cells that recognize specific tumor antigens. For instance, in May 2024, according to the National Cancer Institute, a US-based government agency, there were about 18.1 million cancer survivors in the United States. This figure is projected to rise to 22.5 million by 2032. By 2040, it's expected that the number of new cancer cases each year will reach 29.9 million, with cancer-related deaths estimated to increase to 15.3 million. Therefore, the increasing cases of cancer drive the allogeneic T cell therapies industry.

Who Are The Major Players In The Global Allogeneic T Cell Therapies Market?

Major companies operating in the allogeneic t cell therapies market are Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences Inc., Immatics NV, Sangamo Therapeutics Inc., Poseida Therapeutics Inc., Fate Therapeutics Inc., Atara Biotherapeutics Inc., Sorrento Therapeutics Inc., Autolus Therapeutics Plc, MaxCyte Inc., Tessa Therapeutics Pte Ltd., Cell Medica Inc., Enlivex Therapeutics Ltd., Cellectis SA, Adaptimmune Therapeutics Plc, Medigene AG, Celyad Oncology SA, Allogene Therapeutics Inc., Bellicum Pharmaceuticals Inc.

What Are The Key Trends Of The Global Allogeneic T Cell Therapies Market? Innovative Solutions Enhanced Allogeneic T Cell Therapies Market Growth

Major companies operating in the allogeneic T cell therapies market are focused on developing innovative chimeric antigen receptor (CAR) T-cell therapy initiatives to enhance treatment efficacy and expand therapeutic options. Innovative chimeric antigen receptor (CAR) T-cell therapy initiatives refer to advanced approaches designed to enhance the effectiveness, accessibility, and delivery of CAR T-cell treatments for cancer. For instance, in October 2022, Allogene Therapeutics Inc., a US-based biotechnology company, launched CAR T Together, an innovative initiative to address the challenges of delivering and accessing CAR T therapies. The program focuses on simplifying clinical trial enrollment and fostering collaboration among oncologists to accelerate the development of allogeneic CAR T therapies. Unlike autologous therapies, which are customized from a patient's own cells, allogeneic therapies use T cells from healthy donors, enabling more efficient manufacturing processes.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Allogeneic T Cell Therapies Market? AstraZeneca Plc Acquires Neogene Therapeutics Inc. To Enhance Oncology Pipeline

In January 2023, AstraZeneca Plc, a UK-based pharmaceutical company, acquired Neogene Therapeutics Inc. for an undisclosed amount. Through this acquisition, AstraZeneca seeks to improve patient outcomes by advancing innovative medicines and strengthening its oncology capabilities, particularly in developing cutting-edge therapies for solid tumors that target cancer-specific mutations. Neogene Therapeutics Inc. is a US-based biotechnology company that provides allogeneic T-cell therapies.

What Is The Regional Outlook For The Global Allogeneic T Cell Therapies Market?

North America was the largest region in the allogeneic T cell therapies market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the allogeneic T cell therapies market report areAustralia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Allogeneic T Cell Therapies Market?

The allogeneic T cell therapies market includes revenues earned by entities providing services such as allogeneic CAR-t cell therapy, allogeneic TCR-t cell therapy, allogeneic NK or T cell therapy, off-the-shelf allogeneic t cell therapy, allogeneic virus-specific t cell therapy, and universal donor t cell therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Allogeneic T Cell Therapies Industry?

The allogeneic t cell therapies market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the allogeneic t cell therapies industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Allogeneic T Cell Therapies Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $1.26 billion
Revenue Forecast In 2034 $1.81 billion
Growth Rate CAGR of 9.4% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product Type: Chimeric Antigen Receptor (CAR) T Cell Therapies, T Cell Receptor (TCR) Therapies, Other Product Types
2) By Antigen Type: CD 19, CD 20, Egfrvlll, GD2, CD22, CD30, CD33, Meso, HER1, Other Antigen Types
3) By Therapeutics Indications: Cancer, Autoimmune Diseases, Infectious Diseases, Others Therapeutics Indications
4) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users Subsegments: 1) By Chimeric Antigen Receptor (CAR) T Cell Therapies: CD19-targeted CAR T Therapies, BCMA-targeted CAR T Therapies, CD22-targeted CAR T Therapies
2) By T Cell Receptor (TCR) Therapies: Neoantigen-targeted TCR Therapies, Viral Antigen-targeted TCR Therapies
3) By Other Product Types: Engineered T Cell Therapies, NK Cell Therapies
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences Inc., Immatics NV, Sangamo Therapeutics Inc., Poseida Therapeutics Inc., Fate Therapeutics Inc., Atara Biotherapeutics Inc., Sorrento Therapeutics Inc, Autolus Therapeutics Plc, MaxCyte Inc., Tessa Therapeutics Pte Ltd., Cell Medica Inc., Enlivex Therapeutics Ltd., Cellectis SA, Adaptimmune Therapeutics Plc, Medigene AG, Celyad Oncology SA, Allogene Therapeutics Inc, Bellicum Pharmaceuticals Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Allogeneic T Cell Therapies Market Characteristics

3. Allogeneic T Cell Therapies Market Trends And Strategies

4. Allogeneic T Cell Therapies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Allogeneic T Cell Therapies Growth Analysis And Strategic Analysis Framework

5.1. Global Allogeneic T Cell Therapies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Allogeneic T Cell Therapies Market Growth Rate Analysis

5.4. Global Allogeneic T Cell Therapies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Allogeneic T Cell Therapies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Allogeneic T Cell Therapies Total Addressable Market (TAM)

6. Allogeneic T Cell Therapies Market Segmentation

6.1. Global Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chimeric Antigen Receptor (CAR) T Cell Therapies

T Cell Receptor (TCR) Therapies

Other Product Types

6.2. Global Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

CD 19

CD 20

Egfrvlll

GD2

CD22

CD30

CD33

Meso

HER1

Other Antigen Types

6.3. Global Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cancer

Autoimmune Diseases

Infectious Diseases

Others Therapeutics Indications

6.4. Global Allogeneic T Cell Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Research Institutes

Other End-Users

6.5. Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of Chimeric Antigen Receptor (CAR) T Cell Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

CD19-targeted CAR T Therapies

BCMA-targeted CAR T Therapies

CD22-targeted CAR T Therapies

6.6. Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of T Cell Receptor (TCR) Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Neoantigen-targeted TCR Therapies

Viral Antigen-targeted TCR Therapies

6.7. Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Engineered T Cell Therapies

NK Cell Therapies

7. Allogeneic T Cell Therapies Market Regional And Country Analysis

7.1. Global Allogeneic T Cell Therapies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Allogeneic T Cell Therapies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Allogeneic T Cell Therapies Market

8.1. Asia-Pacific Allogeneic T Cell Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Allogeneic T Cell Therapies Market

9.1. China Allogeneic T Cell Therapies Market Overview

9.2. China Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Allogeneic T Cell Therapies Market

10.1. India Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Allogeneic T Cell Therapies Market

11.1. Japan Allogeneic T Cell Therapies Market Overview

11.2. Japan Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Allogeneic T Cell Therapies Market

12.1. Australia Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Allogeneic T Cell Therapies Market

13.1. Indonesia Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Allogeneic T Cell Therapies Market

14.1. South Korea Allogeneic T Cell Therapies Market Overview

14.2. South Korea Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Allogeneic T Cell Therapies Market

15.1. Western Europe Allogeneic T Cell Therapies Market Overview

15.2. Western Europe Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Allogeneic T Cell Therapies Market

16.1. UK Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Allogeneic T Cell Therapies Market

17.1. Germany Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Allogeneic T Cell Therapies Market

18.1. France Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Allogeneic T Cell Therapies Market

19.1. Italy Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Allogeneic T Cell Therapies Market

20.1. Spain Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Allogeneic T Cell Therapies Market

21.1. Eastern Europe Allogeneic T Cell Therapies Market Overview

21.2. Eastern Europe Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Allogeneic T Cell Therapies Market

22.1. Russia Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Allogeneic T Cell Therapies Market

23.1. North America Allogeneic T Cell Therapies Market Overview

23.2. North America Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Allogeneic T Cell Therapies Market

24.1. USA Allogeneic T Cell Therapies Market Overview

24.2. USA Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Allogeneic T Cell Therapies Market

25.1. Canada Allogeneic T Cell Therapies Market Overview

25.2. Canada Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Allogeneic T Cell Therapies Market

26.1. South America Allogeneic T Cell Therapies Market Overview

26.2. South America Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Allogeneic T Cell Therapies Market

27.1. Brazil Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Allogeneic T Cell Therapies Market

28.1. Middle East Allogeneic T Cell Therapies Market Overview

28.2. Middle East Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Allogeneic T Cell Therapies Market

29.1. Africa Allogeneic T Cell Therapies Market Overview

29.2. Africa Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Allogeneic T Cell Therapies Market Competitive Landscape And Company Profiles

30.1. Allogeneic T Cell Therapies Market Competitive Landscape

30.2. Allogeneic T Cell Therapies Market Company Profiles

30.2.1. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Immatics NV Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Sangamo Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Allogeneic T Cell Therapies Market Other Major And Innovative Companies

31.1. Poseida Therapeutics Inc.

31.2. Fate Therapeutics Inc.

31.3. Atara Biotherapeutics Inc.

31.4. Sorrento Therapeutics Inc

31.5. Autolus Therapeutics Plc

31.6. MaxCyte Inc.

31.7. Tessa Therapeutics Pte Ltd.

31.8. Cell Medica Inc.

31.9. Enlivex Therapeutics Ltd.

31.10. Cellectis SA

31.11. Adaptimmune Therapeutics Plc

31.12. Medigene AG

31.13. Celyad Oncology SA

31.14. Allogene Therapeutics Inc

31.15. Bellicum Pharmaceuticals Inc.

32. Global Allogeneic T Cell Therapies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Allogeneic T Cell Therapies Market

34. Recent Developments In The Allogeneic T Cell Therapies Market

35. Allogeneic T Cell Therapies Market High Potential Countries, Segments and Strategies

35.1 Allogeneic T Cell Therapies Market In 2029 - Countries Offering Most New Opportunities

35.2 Allogeneic T Cell Therapies Market In 2029 - Segments Offering Most New Opportunities

35.3 Allogeneic T Cell Therapies Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Allogeneic T Cell Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of Chimeric Antigen Receptor (CAR) T Cell Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of T Cell Receptor (TCR) Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Allogeneic T Cell Therapies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Allogeneic T Cell Therapies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Bristol-Myers Squibb Company Financial Performance
  • Table 79: Novartis AG Financial Performance
  • Table 80: Gilead Sciences Inc. Financial Performance
  • Table 81: Immatics NV Financial Performance
  • Table 82: Sangamo Therapeutics Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Allogeneic T Cell Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of Chimeric Antigen Receptor (CAR) T Cell Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of T Cell Receptor (TCR) Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Allogeneic T Cell Therapies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Allogeneic T Cell Therapies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Bristol-Myers Squibb Company Financial Performance
  • Figure 79: Novartis AG Financial Performance
  • Figure 80: Gilead Sciences Inc. Financial Performance
  • Figure 81: Immatics NV Financial Performance
  • Figure 82: Sangamo Therapeutics Inc. Financial Performance

Emerging Trends and Growth Drivers in the Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Through 2029

Read More About Emerging Trends and Growth Drivers in the Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Through 2029

Global Leukemia Inhibitory Factor (LIF) Market Landscape: Trends and Market Share to 2029

Read More About Global Leukemia Inhibitory Factor (LIF) Market Landscape: Trends and Market Share to 2029

2025 Medical Amino Acid Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Medical Amino Acid Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Industry Trends Show Medicated Skincare Market Set to Expand at 6.6% CAGR Until 2029

Read More About Industry Trends Show Medicated Skincare Market Set to Expand at 6.6% CAGR Until 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Read More About Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Read More About Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Read More About Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Microsoft Dynamics Global Market Report 2025 – By Solution (Microsoft Dynamics 365 Platform, Microsoft Dynamics Services), By Module (Finance And Accounting, Human Capital Management, Supply Chain Management, Customer Re...

View Report

Cell Therapy Global Market Report 2025 – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy), By Therapy Type (Allogeneic Therapies, Autologous ...

View Report

Cell Therapy Technologies Global Market Report 2025 – By Product (Consumables, Equipment, Systems And Software), By Cell Type (T-Cells, Stem Cells, Other Cells), By Process (Cell Processing, Cell Preservation, Distributi...

View Report

Soil Amendments Global Market Report 2025 – By Soil Type (Clay, Sand, Loam, Silt), By Crop Type (Cereals And Grains, Oilseeds And Pulses, Fruits And vegetables, Other Crop Types), By Product (Organic, Inorganic), By Form...

View Report

Oil And Gas Cloud Applications Global Market Report 2025 – By Component( Solutions, Services), By Operation( Upstream, Midstream, Downstream), By Deployment Model( Hybrid, Private, Public ) – Impact of Tariff and Trade W...

View Report

Cellular Immunotherapy Global Market Report 2025 – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Ce...

View Report

Remote Sensing Services Global Market Report 2025 – By Type( Aerial Photography and Remote Sensing, Data Acquisition and Analytics), By Platform( Defense, Media and Entertainment, Homeland Security Agencies, Agriculture,...

View Report

Brine Concentration Technology (BCT) Global Market Report 2025 – By Technology (High Energy Reverse Osmosis, Mechanical Vapor Compression, Closed Circuit Desalination, Vertical Tube Falling Film, Other Technologies), By ...

View Report

Frequently Asked Questions

Allogeneic T cell therapies are a type of medical treatment where T cells, a crucial component of the immune system, are obtained from a donor (rather than the patient) and used to target and destroy cancer cells in the recipient. Allogeneic T-cell therapies are primarily used in the treatment of various cancers, particularly those that are difficult to treat with conventional methods. For further insights on this market, request a sample here

The market major growth driver - Increasing Cancer Cases Drive Demand For Innovative Therapies. For further insights on this market, request a sample here

The allogeneic t cell therapies market size has grown strongly in recent years. It will grow from $1.16 billion in 2024 to $1.26 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to regulatory approvals, increasing cancer prevalence, rising clinical trials, government funding, and a growing geriatric population. The allogeneic t cell therapies market size is expected to see strong growth in the next few years. It will grow to " $1.81 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to expanding indications, rising demand for cell-based immunotherapies, growing awareness about advanced therapies, increasing healthcare expenditure, and supportive reimbursement policies. Major trends in the forecast period include advancement in research and development activities, personalized medicine, off-the-shelf therapies, global market expansion, strategic partnerships, and regulatory landscape evolution. For further insights on this market, request a sample here

The allogeneic t cell therapies market covered in this report is segmented –
1) By Product Type: Chimeric Antigen Receptor (CAR) T Cell Therapies, T Cell Receptor (TCR) Therapies, Other Product Types
2) By Antigen Type: CD 19, CD 20, Egfrvlll, GD2, CD22, CD30, CD33, Meso, HER1, Other Antigen Types
3) By Therapeutics Indications: Cancer, Autoimmune Diseases, Infectious Diseases, Others Therapeutics Indications
4) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users Subsegments:
1) By Chimeric Antigen Receptor (CAR) T Cell Therapies: CD19-targeted CAR T Therapies, BCMA-targeted CAR T Therapies, CD22-targeted CAR T Therapies
2) By T Cell Receptor (TCR) Therapies: Neoantigen-targeted TCR Therapies, Viral Antigen-targeted TCR Therapies
3) By Other Product Types: Engineered T Cell Therapies, NK Cell Therapies For further insights on this market, request a sample here

North America was the largest region in the allogeneic T cell therapies market in 2024. The regions covered in the allogeneic T cell therapies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the allogeneic t cell therapies market are Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences Inc., Immatics NV, Sangamo Therapeutics Inc., Poseida Therapeutics Inc., Fate Therapeutics Inc., Atara Biotherapeutics Inc., Sorrento Therapeutics Inc., Autolus Therapeutics Plc, MaxCyte Inc., Tessa Therapeutics Pte Ltd., Cell Medica Inc., Enlivex Therapeutics Ltd., Cellectis SA, Adaptimmune Therapeutics Plc, Medigene AG, Celyad Oncology SA, Allogene Therapeutics Inc., Bellicum Pharmaceuticals Inc. . For further insights on this market, request a sample here.

Major trends in this market include Innovative Solutions Enhanced Allogeneic T Cell Therapies Market Growth. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Allogeneic T Cell Therapies Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon